Form 4: Lemaitre Vascular Inc. Executive David B. Roberts Reports Acquisition of Dividend Equivalent Rights

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the acquisition of dividend equivalent rights related to previously granted stock awards.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc., filed a Form 4 disclosing the acquisition of dividend equivalent rights.
• These rights are associated with restricted stock unit and performance share unit awards granted on various dates between 2019 and 2023.
• The dividend equivalent rights vest proportionately with the underlying stock awards and are economically equivalent to one share of Lemaitre Vascular's common stock.
• A total of 13.0863 dividend equivalent rights were acquired on December 5, 2024, across six different grants.
• The acquisition of these rights does not involve a direct purchase of shares but rather an accrual of rights based on existing equity awards.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of executive compensation, which is generally neutral. The acquisition of dividend equivalent rights is a positive sign of alignment between management and shareholders, but it is not a major event.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of executive interests with shareholder value.
• The vesting of these rights alongside existing equity awards encourages long-term performance and retention.

Industry Context

This filing is a routine disclosure of executive compensation and is typical for publicly traded companies. It reflects the ongoing practice of using equity-based compensation to align executive interests with shareholder value.

Comparison to Industry Standards

• The use of dividend equivalent rights is a common practice in executive compensation packages, particularly for companies that issue stock-based awards.
• Many companies in the medical device sector, such as Medtronic and Boston Scientific, also utilize similar equity-based compensation structures.
• The vesting schedules and terms of these rights are generally consistent with industry norms for executive compensation.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor positive impact on shareholders by aligning executive interests with company performance.
• The vesting of these rights encourages long-term value creation.

Key Dates

Keywords

dividend equivalent rights, Form 4, Lemaitre Vascular Inc, executive compensation, stock awards, David B. Roberts, LMAT, restricted stock units, performance share units